NEW YORK (
Zoll Medical Corporation
) hit a new 52-week high Wednesday as it is currently trading at $48.23, above its previous 52-week high of $48.09 with 161,752 shares traded as of 2:16 p.m. ET. Average volume has been 171,800 shares over the past 30 days.
Zoll Medical has a market cap of $1 billion and is part of the
industry. Shares are up 27.8% year to date as of the close of trading on Tuesday.
ZOLL Medical Corporation, together with its subsidiaries, develops and markets medical devices and software solutions in the United States and internationally. The company has a P/E ratio of 50, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.7.
- Practice your ZOLL trading strategies and win cash in our stock game.
TheStreet Ratings rates Zoll Medical as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
52-week high stocks
or get investment ideas from our